Table 2

Prevalence of systolic dysfunction and systolic heart failure by sex and age (LVEF ⩽ 40)

Age (years)No.Non-treatedTreated*Symptomatic* (treated and non-treated)†Total
*ACE inhibitors, β blockers, diuretics, or digitalis; †dyspnoea, ankle oedema, or both.
Women50–591240 (0%)0 (0%)1 (0.8%)1 (0.8%)
60–691020 (0%)0 (0%)1 (1.0%)1 (1.0%)
70–791121 (0.9%)0 (0%)4 (3.6%)5 (4.5%)
80–89930 (0%)0 (0%)4 (4.3%)4 (4.3%)
Total50–894311 (0.2%)0 (0%)10 (2.3%)11 (2.6%)
Men50–591143 (2.6%)0 (0%)2 (1.8%)5 (4.4%)
60–691023 (2.9%)0 (0%)2 (2.0%)6 (5.9%)
70–79791 (1.3%)2 (2.5%)5 (6.3%)8 (10.1%)
80–89360 (0%)1 (2.8%)5 (13.9%)6 (16.7%)
Total50–893317 (2.1%)4 (1.2%)14 (4.2%)25 (7.6%)
Total men and women50–897628 (1.0%)4 (0.5%)24 (3.1%)36 (4.7%)